AHA GUIDELINES Bundle (free trial)

Dyslipidemia 2026

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1543908

Contents of this Issue

Navigation

Page 3 of 105

4 Definitions and Classifications Note: The numbering of the following tables and figures may differ from that of the Clinical Practice Guideline. Colors in tables and figures correspond to Class of Recommendations and Level of Evidence tables on pages 104–105. 2.1. Definitions ➤ Cardiovascular-kidney-metabolic syndrome: The common characteristics of the cardiovascular-kidney-metabolic (CKM) syndrome include abdominal obesity (high body mass index [BMI] and/or large waist circumference), insulin-resistant glucose metabolism (hyperinsulinemia, impaired fasting glucose, impaired glucose tolerance, type 2 diabetes), dyslipidemia (high serum TG and low serum high-density lipoprotein cholesterol [LDL-C] concentrations), increased blood pressure, and sometimes microalbuminuria, proteinuria, or chronic kidney disease (CKD). ➤ Children: In this guideline, children are defined as age 18 years or younger. ➤ Clinical ASCVD: ASCVD includes history of acute coronary syndromes (ACS), myocardial infarction (MI), stable or unstable angina, coronary or other arterial revascularization, stroke, transient ischemic attack (TIA), or peripheral artery disease (PAD). ASCVD at very high risk is defined as ≥2 major ASCVD events (ACS within the past 12 months, history of MI [other than recent ACS], history of ischemic stroke, symptomatic PAD) or with 1 major ASCVD event and ≥2 high-risk features (age ≥65 years, coronary bypass or percutaneous intervention, current smoker, diabetes, history of heart failure [HF], hypertension, LDL-C ≥100 mg/dL [2.6 mmol/L] despite maximally tolerated statin plus ezetimibe). ➤ Dyslipidemias: Dyslipidemias considered in this guideline include elevated blood cholesterol, hypertriglyceridemia, and elevated Lp(a). ➤ Lifestyle management: Lifestyle management encompasses an assessment of each individual's baseline behavioral habits and counseling regarding healthy lifestyle habits. It includes information regarding heart-healthy eating patterns, regular physical activity, avoidance of all nicotine-delivery products, healthy sleep habits, and maintaining a healthy weight. This includes the lifestyle elements of the AHA's Life's Essential 8 ™ in addition to stress management. ➤ Subclinical atherosclerosis: Subclinical atherosclerosis is identified by the presence of atheromatous disease in ≥1 arterial territories before there are any signs, symptoms, or events attributable to clinically manifest atherosclerotic disease in those territories.

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Dyslipidemia 2026